2017 SPARS scenario and the 2020 SARS-CoV-2 Spike reality with Monkeypox opportunities.
Update: 6/24/2022 New insight into most recent Monkeypox publication.
Urgent update: 6/30/2022 Smallpox (Jynneos) MVA-BN vaccine and SPIKE overlap! (is it Bavarian Nordic or actually Pfizer, again???)
Update: 7/1/2022 Dr. David Martin’s most recent interview: https://forbiddenknowledgetv.net/700-million-worldwide-will-die-from-cv19-vax-by-2028-dr-david-martin/
and also: https://www.bitchute.com/video/Fxm2lV3cGVYC/
7/11/2022 : Dr. Ardis solutions to covid issues (!!!) https://www.bitchute.com/video/f14BZ78e8OgS/
7/24/2022: The ugly neck of the deep state announces yet another ‘emergency’: https://www.nowtheendbegins.com/who-world-health-organization-declares-monkeypox-to-be-global-health-emergency-bill-gates/
Update 11/15/2022: “Roche Receives FDA Emergency Use Authorization for Cobas Monkeypox Test | staff reporter“ at https://www.genomeweb.com/regulatory-news-fda-approvals/roche-receives-fda-emergency-use-authorization-cobas-monkeypox-test
Update 12/15/2022: The US Centers for Disease Control and Prevention has awarded a $5 million contract to Helix to create a pan-respiratory viral surveillance program, the firm announced on Thursday, in an article titled “Helix Wins $5M CDC Contract for Pan-Respiratory Viral Surveillance Program“ at https://www.genomeweb.com/business-news/helix-wins-5m-cdc-contract-pan-respiratory-viral-surveillance-program
In 2017 John Hopkins Center for Health Security published document with the title: ‘SPARS PANDEMIC 2025-2028’ (available at: https://jhsphcenterforhealthsecurity.s3.amazonaws.com/spars-pandemic-scenario.pdf) which presented a futuristic scenario of a 3 years (we are slowly almost there) health crisis story in which Hoofed Mammal Respiratory Coronavirus Outbreak Model was assumed for 2021.. This jhsphcenterforhealthsecurity link does NOT WORK ANYMORE, today as of 12/29/2023…. The document is available at: https://canadahealthalliance.org/wp-content/uploads/2022/06/spars-pandemic-scenario.pdf
There was an in-house development of a potential vaccine named HMRV-vac14, with the remarkably similar features to covid injections, quote: “HMRV-vac14 has not been tested or authorized by any governing agency for use in animals or humans“. And further: “federal health authorities awarded a contract to CynBio, a US-based pharmaceutical company, to develop a SPARS vaccine based on the GMI model.”
The ‘CynBio’ could stand for a cynical way to indicate Synthetic Biology, it is all what geneticists are dreaming of, to ‘reconstruct the nature from scratch’. An example of these companies: https://www.synbioco.com/aboutus
and the plan to develop the products for a GLOBAL crisis is summarized in this article^1 “Build a Sustainable Vaccines Industry with Synthetic Biology“ pointing to the 2015 WEF plan for two out of 10 goals ( https://www.weforum.org/agenda/2015/03/top-10-emerging-technologies-of-2015-2/ )
4. Precise genetic engineering techniques.
10. Digital genome.
and the flow diagram of what will be done where:
With lot of details hidden to the general public, the above diagram doesn’t include for example the ukrainian biolabs, with METABIOTA Inc. , participating in the development of many of the bioweapons, always aiming in a ‘vaccine’ as the solution to the problem. A good general overview is given by Dr. Lee Merritt at https://www.bitchute.com/video/gsmIEpRoSsQ5/
Preparations for the human genome editing started long time ago, but the official steps were first, patenting by NIH the method (“Lentiviral protein delivery system for rna-guided genome editing”) and in March 2022 FDA introduced the guidelines for the experimental implementation of the redesigning of the human beings (https://www.fda.gov/media/156894/download). Page 6 of this document titled “Human Gene Therapy Products Incorporating Human Genome Editing” states, quote: “For ex vivo genome modification, the cell type of interest may be amenable to electroporation or mechanical methods, in which case the GE components may be
delivered as DNA, RNA, protein or ribonucleoprotein complexes (RNPs) for
CRISPR/Cas9.“ and further “Viral vectors may support sustained expression of GE component transgenes, and nanoparticles may allow the temporal delivery of GE components as messenger RNAs or proteins.“ So far all the definitions fit the type of the substances used in covid19 injection materials.
Back to SPARS document though. So does anything like the futuristic ‘vac14’ even exist? Yes, the uniprot entry of that protein can be found at: https://www.uniprot.org/uniprot/Q08AM6
and it is involved in the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Due to its binding to PIKFYVE and FIG4 it participates in maintaining normal levels of the phospholipids found in cell membranes. PIKFYVE protein loss is directly involved in the spongiform degeneration in prion diseases^2. VAC14 however due to its genetic mutation is known to be involved in s.c. Striatonigral degeneration, childhood-onset (SNDC), an autosomal recessive neurological disorder characterized by sudden childhood onset of developmental regression. So is VAC14 somewhat related to the SARS-CoV-2 Spike protein, genome of which is being injected into billions of people? NIH BLAST runs with custom parameters show an average of ~30% identities with almost full sequence coverage, here some examples of the sections of homologies (Query represents the HUMAN VAC14 amino acid sequence, and Sbjct the SARS-CoV-2 Spike sequence):
22.3 bits(45) 0.19 9/20(45%) 10/20(50%) 8/20(40%)← stats for the first hit
Query 231 EIR--------KMCEVVLGE 242 Human VAC14 homolog
EIR KM E VLG+ <<IDENTITIES
Sbjct 1017 EIRASANLAATKMSECVLGQ 1036 Spike2020
Query 647 DLI--QKFGDLEVTV 659 Human VAC14 homolog
DLI QKF L TV <<IDENTITIES
Sbjct 848 DLICAQKFNGL--TV 860 Spike2020
Query 312 DRKKSIKEVA-NVCNQSLMKLVTPEDDELDEL 342
DR EVA N N+SL +L EL
Sbjct 1184 DR---LNEVAKNL-NESLI--------DLQEL 1203
or
Query 298 SGILTAVLPCLAYDDRKKSIKEVANVCNQSLMKL 331
SGI +V+ DR + EVA N+SL+ L
Sbjct 1170 SGINASVVNIQKEIDR---LNEVAKNLNESLIDL 1200
Query 619 CCLYRSWC 626
CC S C
Sbjct 1247 CCSCGSCC 1254
Query 164 IVTESNK 170
++TESNK
Sbjct 551 VLTESNK 557
Query 209 NLLDYLPEILDGLFQI 224
NL +++ + +DG F+I
Sbjct 188 NLREFVFKNIDGYFKI 203
Query 648 LIQKFGDLE-VTVDFLAEVDKLVQLIECPIFTYLRLQLLDVKNNPYLIKA
L FG + V D L+ +DK+ ++ RLQ L LI+A
Sbjct 966 LSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRA
Query 170 KFDLVSFIPLLR 181
KFD P+L+
Sbjct 1255 KFDEDDSEPVLK 1266
Query 185 YSNNQYARQFIISWILVLESVPDINLLDYLPEIL 218
YSNN A +P + EIL
Sbjct 707 YSNNSIA-------------IPTNFTISVTTEIL 727
Query 18 LNDKLYEKR--KV-AALEIEKLV 37
LND L R KV A +I+ L+
Sbjct 977 LNDIL--SRLDKVEAEVQIDRLI 997
Query 203 ESVPDINLLDYLP---EILD 219
+ V D P EILD
Sbjct 574 DAVRD-------PQTLEILD 586and countless more sections. Even though VAC14 is not a prion protein it does contain five of the GxxxG characteristic prion motifs in its sequence. Few publications about functional importance of VAC14 include its:
1. modulation of the synaptic function^3
2. modulation of cholesterol^4
3. neurodegeneration in mice^5
4. brain IRON accumulation with altered homodimer formation^6, ^7
The pathological function no 4. described in ^7 was traced with the brain magnetic resonance imaging (MRI), and revealed abnormal magnetic susceptibility in the globus pallidus, which can be seen in neurodegeneration with brain iron accumulation (NBIA). This point is maybe related to the most recent Prof. Burkhardt’s investigation of the deceased bodies of the covid injected, when he observed exactly that condition, iron deposits in the brain….
Despite of the fact that there are worlds between a human and a mouse, the usually researched ‘Model of VAC14 knock-out mice’, i.e. a mouse without that VAC14 protein, does not look good (https://en.wikipedia.org/wiki/VAC14). Here the quote:
“A mice without VAC14 die at, or shortly after birth and exhibit massive neurodegeneration. Fibroblasts from these mice display ~50% lower levels of PtdIns(3,5)P2 and PtdIns(5)P.[13] A spontaneous mouse VAC14-point mutation (with arginine substitution of leucine156) is associated with reduced life span (up to 3 weeks), body size, enlarged brain ventricles, 50% decrease in PtdIns(3,5)P2 levels, diluted pigmentation, tremor and impaired motor function.[14]”
Those who didn’t read any of my previous posts implying the importance of every single amino acid in the human body:
or
have to know, that for every production of a single synthetic Spike toxin (not even talking about the injected SYNTHETIC Spike GENE) in all the ‘transfected’ human cells there are thousands of extremely important human building blocks, which are literally stolen from the body of the covid injected victim, in order to, at the very end, supposedly build up the ‘synthetic immunity’ towards computer generated UNIVERSAL genetic SARS-CoV-2 Spike sequence in every human on the entire planet. I hope people will finally start to see the immense betrayal by the ‘science’ which is proudly marching with every injection, towards by the WEF desired ‘Digital genome’. It is all criminal. Every synthetic genetic material injection is defined as gene modification treatment, here an example with a quote from GenomeWeb at https://www.genomeweb.com/microarrays-multiplexing/founder-events-common-human-dog-populations-study-finds for everyone:
“Tissue-Based Gene Therapy Biodistribution Analysis Using In Situ Hybridization
This report from ACD demonstrates the use of the RNAscope assay to visualize therapeutic adeno-associated virus vector cell tropism and transgene expression in non-human primate retina, simultaneously detecting vector DNA and transgene RNA and identifying specific cell populations using cell markers and vector probes.”
in other words, the transgenic RNA materials in different tissues GUIDE the Gene Therapy of those organs.
It is strange that the SPARS document didn’t mention Monkeypox, the next 'scientific target with unlimited opportunities’, with (955 variant positions in a 137 668 bp alignment) 52 Monkeypox viral sequences… That’s out of the “ First draft genome sequence of Monkeypox virus associated with the suspected multi-country outbreak, May 2022 (confirmed case in Portugal) ”.
Today’s new publication by Isidro J et al. in Nature Medicine with the title: ”Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of mokeypox virus” talks about ‘accelerated viral evolution’ of the newly sequenced pox virus due to human APOBEC3 protein, a DNA dC->dU-editing enzyme (https://www.uniprot.org/uniprot/Q96AK3), capable of converting the cytosine to uracil in -ssvirDNA. That protein acts as an inhibitor of retrovirus replication, i.e. exhibits antiviral activity against Vif-deficient HIV-1 and it also inhibits the mobility of LTR and non-LTR retrotransposons, the same family of proteins which integrated the SARS-CoV-2 genes into certain human cells^8. So if we take more of human building blocks for the synthetic Spike production, via covid injections, we end up having distorted metabolic profile for that APOBEC3 protein, among thousands if not million others. How many building blocks? NIH BLAST package says also about 30% of APOBEC3 ingredients are identical with SARS-CoV2 Spike. Few examples:
15.8 bits(29) 7.9 7/22(32%) 10/22(45%) 0/22(0%)
Query 185 KFDDNYASLHRTLKEILRNPME 206 DNA editing HUMAN enzym
K NY L+R ++ P E IDENTITIES
Sbjct 444 KVGGNYNYLYRLFRKSNLKPFE 465 Spike2020
Query 243 AVFRKRGVF-----------RNQVDPETHCHAERCFLSWFCDDILS--PNTNYE 283
A F + GVF RN +P+ + F+S CD ++ NT Y+
Sbjct 1087 AHFPREGVFVSNGTHWFVTQRNFYEPQI-ITTDNTFVSGNCDVVIGIVNNTVYD 1139
Query 337 EGASVKIMGYKDFVSCWKNF-----VYSDDEPFKPWKGLQTNFRLLK 378
EG ++FV +KN +YS P + L F L+
Sbjct 180 EGKQGNFKNLREFV--FKNIDGYFKIYSKHTPINLVRDLPQGFSALE 224
Query 70 EVYFRFENHAEMCFLSWFCGNRLPANRRFQITWFVS---WN 107
E RF N +C P F T F S WN
Sbjct 324 ESIVRFPNITNLC----------PFGEVFNATRFASVYAWN 354
Query 60 LPKRQSNHRQEVYFRFEN 77
L +Q N + F F+N
Sbjct 179 LEGKQGNFKNLREFVFKN 196
in average there are less overlaps of the Monkeypox accelarting human enzyme in the Spike, then in the VAC14 protein, plus the overlapping sections are not so extended. Given that the official science is always in advance with its ‘special goals paid by those in power’, the question would be, why suddenly a super fast evolution of Monkeypox by a human DNA cutting enzyme, affecting the same protein which is already responsible for changing the human genome by the SARS-CoV-2? The ‘plandemic switch’ from a ss+ RNA virus, which was partly GENETICALLY replicated in human cells via the covid synthetic injections, now to an extremely complex ds-DNA virus, must have a purpose, which surely the injections producers must know about.
Let’s hope it is all a 2017 fiction! But, well, thank you Johns Hopkins Bloomberg School of Public Health for this VAC14 hint to check out your 2017 predictions, paid by the Open Philanthropy Project, i.e. Dustin Moskovitz, the very same who paid for the prophetic EVENT201, also sponsored by WEF and the usual suspects, Bill and Melinda.. Isn’t that strange that Dustin Moscovitz ALSO OWNS the Sherlock Biosciences:
which quote:”One of Sherlock Biosciences’ key technologies comes from the MIT Broad Institute lab of Feng Zhang, who did some of the early work elucidating the DNA-modifying potential of CRISPR and its associated enzymes after their discovery in bacteria.” with the famous Sherlock now having: “Specific High sensitivity Enzymatic Reporter unLOCKing”. All the info thanks to Dr. David Martin!!!
Just wonder, who is Dustin’s father??? Nowhere any info, strange, too many Moscovitz’.. Just let’s hope, it is NOT the late Irving Moskowitz (January 11, 1928 – June 16, 2016) who established the Moskowitz Prize for Zionism in 2008, according to wiki… Just wonder, was the 201 event out there to honor the year 2001, with the clear participation of zionists?? Just LOT of speculations here..
Back to Monkypox:
6/30/2022: https://www.precisionvaccinations.com/vaccines/jynneos-smallpox-monkeypox-vaccine link
points to more in detail description of the Smallpox vaccine in 2 places https://www.bavarian-nordic.com/pipeline/technology/mva-bn.aspx
and https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Smallpox-Jynneos whereby the later lists the FDA JYNNEOS package insert at https://www.fda.gov/media/131078/download
When you read this, it appears, that the SAE’s (serious side effects) of Bavarian Nordic vaccine using the Modified Vaccinia Ankara virus variant (from Patent https://patents.google.com/patent/US7923017B2/en) are causing some overlapping symptoms to covid gene therapy injection materials, for example troponin-I elevated above 2 times the upper limit of normal, and for the monkeypox injections additionally cardiac AESIs were reported with electrocardiogram T wave inversion, electrocardiogram abnormal, electrocardiogram ST segment elevation, electrocardiogram T wave abnormal, and palpitations. So assuming all the injections are consisting of totally healthy ingredients(???, a joke) and the differences are ‘just’ in the genetic sequences of the injected proteins (in case of JYNNEOS, in comparison to the genome in case of SPike) what is then common between the Spike and the attenuated MVA virus what causes the heart issues??? Running NIH BLASTx with the accession DQ983238.1 for the entire monkeypox viral genome and YP_009724390.1 for the SARS-Cov-2 Spike protein, gives the following overlapping sections with ~37% of identities:
26.2 1.067e+05 82% 0.87 37.21% 1273 YP_009724390.1
these identities are astonishing, here examples of the overlaps with Query line indicating monkeypox proteins and Subjct line the SARS-CoV2- Spike:
26.2 bits(56) 0.87 Compositional matrix adjust. 16/43(37%) 25/43(58%) 3/43(6%) -2
Query 112462 KEGFKLDESIKSILLVNPSSIDLLKIRVYKHRIKWMGDIFVLF 112334
KE +L+E K++ N S IDL ++ Y+ IKW I++ F
Sbjct 1181 KEIDRLNEVAKNL---NESLIDLQELGKYEQYIKWPWYIWLGF 1220
25.4 bits(54) 1.6 Compositional matrix adjust. 23/110(21%) 46/110(41%) 10/110(9%) -2
Query 17791 FTAMILMSPLVNADAVSRLNLLAAKLMGTITPNAPVGKLCPESVSRDMDKVYKYQ----- 17627
F + ++ PL+ + +++ +A L GTIT G + M Y++
Sbjct 855 FNGLTVLPPLLTDEMIAQYT--SALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVT 912
Query 17626 YDPLINHEKIKAGFASQVLKATNKVRKIISKINTPTLILQGTNNEISDVL 17477
+ L ++K+ A+Q A K++ +S + LQ N+ + L
Sbjct 913 QNVLYENQKL---IANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQAL 959
FURIN SITE:
Query VGCCDHLHRINNYVWCRLKFHIVTDAVYRSSHRNQRRSKSNYRQNRSQYLFFICHNLRAS 100402
GC +NN C + A Y++ + RR++S Q+ Y + +
Sbjct 647 AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVA 706
Query 100403 SMNN 100414
NN
Sbjct 707 YSNN 710
22.7 bits 15/44(34%) 24/44(54%) 11/44(25%) +3
Query 85596 SHYRVSKHITIVRYKDTEELNLTRIC-----YNRDKFKAFVFAW 85712
S++RV +IVR+ N+T +C +N +F A V+AW
Sbjct 316 SNFRVQPTESIVRFP-----NITNLCPFGEVFNATRF-ASVYAW 353
Query 91262 NKTRFDTLLSLH 91227
N TRF TLL+LH
Sbjct 234 NITRFQTLLALH 245
Query 154186 EKEFTSDYPFYVSPTEMV----DVSMMSMYGELFN 154278
EK F V PTE + +++ + +GE+FN
Sbjct 309 EKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFN 343
Query 91605 PINIHSDQLS-KFRTLLSSSN 91546
P+ IH+DQL+ +R + SN
Sbjct 621 PVAIHADQLTPTWRVYSTGSN 641
Query 19957 ESYIDTIEVYNHHTY---SWNIWDG 19892
ES ID E+ + Y W IW G
Sbjct 1195 ESLIDLQELGKYEQYIKWPWYIWLG 1219
Query 109061 TGRI--LSRYTSKQ*HRTSYSRSSKCC-----SECNRGASKR 108957
TGR+ L Y ++Q R + R+S SEC G SKR
Sbjct 998 TGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKR 1039
Query 127945 CN----GLYY-QGSCYILHSDYQLFSDAKANCTAESSTLP 128049
CN G+YY + + + S+++++S A NCT E + P
Sbjct 136 CNDPFLGVYYHKNNKSWMESEFRVYSSAN-NCTFEYVSQP 174
Query 91545 HDGKPHYITEN 91513
HDGK H+ E
Sbjct 1083 HDGKAHFPREG 1093
Query 140515 CVVMLIDKDLKIKAGPRYVLNAISPHAYDVFRKSN 140619
CV+ +L K G Y + Y +FRKSN
Sbjct 432 CVIAWNSNNLDSKVGGNY------NYLYRLFRKSN 460
Query 38450 KEMVNKYFEN------------PLHIIGKNLQECIDFVSE*AFHLSPILIQIVKL 38578
KE ++KYF+N ++ N+Q+ ID ++E A +L+ LI + +L
Sbjct 1149 KEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL 1203
Query 98657 DLICAKKF 98680
DLICA+KF
Sbjct 848 DLICAQKF 855
Query 124545 DEDDNEETLK 124516
DEDD+E LK
Sbjct 1257 DEDDSEPVLK 1266
Query 31982 EFSFCICSYSVLY 32020
S C+ YSVLY
Sbjct 357 RISNCVADYSVLY 369
Query 56288 CYTDVYSS*WIIR 56326
C+T+VY+ ++IR
Sbjct 391 CFTNVYADSFVIR 403
Query 154656 TSCCSC 154639
TSCCSC
Sbjct 1238 TSCCSC 1243
Query 137595 YNKYSFKLILAEYIR--HRNTISGNIYSALMTLDDLAIKQYGD 137717
+ ++F IL + + R+ I +++ + D IKQYGD
Sbjct 797 FGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGD 839
Query 105551 SYQSKTNWVKKDHSASSR 105498
SYQ++TN ++ S +S+
Sbjct 673 SYQTQTNSPRRARSVASQ 690and countless more! There is the furin site, the RBD sections, the HIV-1 homolog infectious sequence, the countless times patented ‘PSKPSKRSFIEDLLFNKVT’ peptide, etc., etc. And now try to look just on its own, for one section of the found overlaps, for example:
20.4 bits(41) 57 Composition-based stats. 13/40(33%) 23/40(57%) 6/40(15%) +1
Query 127945 CN----GLYY-QGSCYILHSDYQLFSDAKANCTAESSTLP 128049
CN G+YY + + + S+++++S A NCT E + P
Sbjct 136 CNDPFLGVYYHKNNKSWMESEFRVYSSAN-NCTFEYVSQP 174 Spike2020with a search for ‘GLYYQGSCYILHSDYQLFSDAKANCTAESSTLP’ peptide among patented proteins. You will find 3 further patents carrying exactly that peptide:
-Compositions for the prevention and treatment of smallpox. US 8795667-B2 MacroGenics, Inc. Rockville, MD 05-AUG-2014
- Compositions, methods and kits relating to poxvirus subunit vaccines. US 7560116-A The Trustees of the University of Pennsylvania; Philadelphia, PA; US;14-JUL-2009
- Smallpox DNA vaccine and the antigens therein that elicit an immune response. US 8535687-B2 The Trustees of the University of Pennsylvania and Inovio Pharmaceuticals, Inc.; Philadelphia, PA US; 17-SEP-2013
The net of the involved ‘health care’ professionals, is just mindblowing!
The last addition here is equally astonishing. Countless runs of sections of the DQ983238.1 entry, which is the approved Bavarian Nordic Moneypox vaccine, indicate in turn homologies with the following patent: JP 2010252797-A/4: NOVEL INSERTION SITES IN POX VECTORS. GenBank: FW576867.1. It is from 2010 with priority date 20-FEB-2003 US 60/448591, and its owner:
FOUNDATION WYETH LLC SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES.
according to Wiki: Most Wyeth's pharmaceutical assets were acquired by Pfizer in 2009,[1][2] while its infant and maternal nutrition business was acquired by Nestlé in 2012.
When comparing the Bavarian Nordic DQ983238.1 and the 2009 WYETH’s sequence FW576867.1, it appears it has 99.9% sequence homology and 100% IDENTITY, meaning, Bavarian’s sequence is Pfizer’s sequence. Just one of the sections as compared by NIH BLAST package, attached at the end of this post. No wonder we have so many analogies between 2020 corona’s Spike and now the coming Monkybussiness!!!
Can you now believe announcements like this one at https://www.pharmalive.com/bavarian-nordic-takes-on-pfizer-biontech-with-covid-19-booster-candidate/
”Denmark-based biotech company Bavarian Nordic announced Thursday that the upcoming Phase III trial for ABNCoV2, its COVID-19 booster candidate, has been redesigned to compete against Pfizer–BioNTech‘s mRNA-based vaccine.”?????
It gets even better, begin of 2021, a ‘RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS’ was entered at https://patents.justia.com/patent/20210260182. When reading that description, all the left over hair will start to stand up on a thinking scull, quote:
“In some embodiments, the poxvirus belongs to a genus of Chordopoxvirinae subfamily selected from Avipoxvirus, Capripoxvirus, Cervidpoxvirus, Crocodylipoxvirus, Leporipoxvirus, Molluscipoxvirus, Orthopoxvirus, Parapoxvirus, Suipoxvirus, or Yatapoxvirus. In some embodiments, the recombinant poxvirus is an Orthopoxvirus. In some embodiments, the Orthopoxvirus is selected from the group consisting of camelpox virus (CMLV), cowpox virus (CPXV), ectromelia virus (ECTV, “mousepox agent”), horsepox virus (HPXV), monkeypox virus (MPXV), rabbitpox virus (RPXV), raccoonpox virus, skunkpox virus, Taterapox virus, Uasin Gishu disease virus, vaccinia virus (VACV), variola virus (VARV) and volepox virus (VPV). In some embodiments, the poxvirus is a Parapoxvirus. In some embodiments, the Parapoxvirus is selected from orf virus (ORFV), pseudocowpox virus (PCPV), bovine popular stomatitis virus (BPSV), squirrel parapoxvirus (SPPV), red deer parapoxvirus, Ausdyk virus, Chamois contagious ecythema virus, reindeer parapoxvirus, or sealpox virus. In some embodiments, the poxvirus is a Molluscipoxvirus. In some embodiments, the Molluscipoxvirus is molluscum contagiousum virus (MCV). Any of the synthetic poxviruses disclosed in US 2018/0251736 and WO 2019/213452, may be used to generate a recombinant poxvirus comprising a SARS-CoV-2 protein, as disclosed herein.“
What the hell is FDA approving, universal genetic NON-random codes for every new injection material representing the entire ZOO, which all have so much in common??? Do they hope with infinite amount of boosters to finally reprogram every single stem cell in the human body and make out of it, WHAT? All these similarities among totally different viruses, hosts, diseases???? Can anyone finally ask FDA/CDC/NIH what's their purpose with first injecting everyone with the PATENTED subjct sequences and then planning on to inject the PATENTED Query line sequence into everyone???? And that all while in the meantime the human body needs for its HUMAN functions every single of these amino acids??? For every single deceased and injured HUMAN after the covid GENE THERAPY, the amount of punishment for all the responsible and involved should be lifelong prison. Yes Walensky, Fauci, etc., you all heard it right, as one of the medical doctors told you in your face just recently, you will burn in hell, for what you’ve done and are doing now, even to the CHILDREN!
Literature
Trends Biotechnol. 2021 Jan 8 at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834237/
EMBO Mol Med. 2021 Sep 7; 13(9): e14714. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518562/
EMBO J. 2012 Aug 15; 31(16): 3442–3456. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419932/
“Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol” https://www.pnas.org/doi/10.1073/pnas.1706070114
“Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077288/
“Altered homodimer formation and increased iron accumulation in VAC14-related disease: Case report and review of the literature” https://pubmed.ncbi.nlm.nih.gov/32949958/
“Title: VAC14 syndrome in two siblings with retinitis pigmentosa and neurodegeneration with brain iron accumulation“
“Zhang L. et al. “Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues”. Proc. Natl. Acad. Sci. USA. 2021;118 e2105968118.“
Small section of the tblastX output comparing DQ983238.1 with FW576867.1:
ScoreExpectIdentitiesPositivesGapsFrame 3159 bits(6889) 0.0 1388/1389(99%) 1389/1389(100%) 0/1389(0%) -2/-2
Query 111244 GAPRRRTTVTTTSYNAMDGQIVQAVTNAGKIVYGTVRDGQLEVRGMVGEINHDLLGIDSV 111065 GAPRRRTTVTTTSYNAMDGQIVQAVTNAGKIVYGTVRDGQLEVRGMVGEINHDLLGIDSV Sbjct 117883 GAPRRRTTVTTTSYNAMDGQIVQAVTNAGKIVYGTVRDGQLEVRGMVGEINHDLLGIDSV 117704 Query 111064 NAGkkkpskkmptnkKINMSSGMRRQEQINPDDCCLDMGMY*IK*F*FV*RIS*V*TIQY 110885 NAGKKKPSKKMPTNKKINMSSGMRRQEQINPDDCCLDMGMY*IK*F*FV*RIS*V*TIQY Sbjct 117703 NAGKKKPSKKMPTNKKINMSSGMRRQEQINPDDCCLDMGMY*IK*F*FV*RIS*V*TIQY 117524 Query 110884 *EPDCYRFLVLMLQHRSHLRSPHR*FLK*YRYSVL*FLQIRVLAMLAR*YL*Q**SR**R 110705 *EPDCYRFLVLMLQHRSHLRSPHR*FLK*YRYSVL*FLQIRVLAMLAR*YL*Q**SR**R Sbjct 117523 *EPDCYRFLVLMLQHRSHLRSPHR*FLK*YRYSVL*FLQIRVLAMLAR*YL*Q**SR**R 117344 Query 110704 *FFVFYFRDIV*SFYRFYLFHPLNKHPSPRLIRETRSNLHN*RWLYAY*LLLIYTESYQI 110525 *FFVFYFRDIV*SFYRFYLFHPLNKHPSPRLIRETRSNLHN*RWLYAY*LLLIYTESYQI Sbjct 117343 *FFVFYFRDIV*SFYRFYLFHPLNKHPSPRLIRETRSNLHN*RWLYAY*LLLIYTESYQI 117164 Query 110524 VFW*NYLNYQMILY*IVDF*D*PLHPPTSEFFYLYHKLLPRMVFVLA*KIS*I*IPLLLQ 110345 VFW*NYLNYQMILY*IVDF*D*PLHPPTSEFFYLYHKLLPRMVFVLA*KIS*I*IPLLLQ Sbjct 117163 VFW*NYLNYQMILY*IVDF*D*PLHPPTSEFFYLYHKLLPRMVFVLA*KIS*I*IPLLLQ 116984 Query 110344 HFSIL*Y*IFFLVVDVVPISITLYET*EVEYRQ***YEVVLVR**WPENHHLEIDLH*VV 110165 HFSIL*Y*IFFLVVDVVPISITLYET*EVEYRQ***YEVVLVR**WPENHHLEIDLH*VV Sbjct 116983 HFSIL*Y*IFFLVVDVVPISITLYET*EVEYRQ***YEVVLVR**WPENHHLEIDLH*VV 116804 Query 110164 RIFPLEMTLRRHYVLYLPRC*RELE*TFDEELFHNFC*MDNYLLKTL*LNRFVYPSLVRS 109985 RIFPLEMTLRRHYVLYLPRC*RELE*TFDEELFHNFC*MDNYLLKTL*LNRFVYPSLVRS Sbjct 116803 RIFPLEMTLRRHYVLYLPRC*RELE*TFDEELFHNFC*MDNYLLKTL*LNRFVYPSLVRS 116624 Query 109984 SFNTK*MMPIKSIVTLDQLEDSEYLFRIVSTVLPHLCLDYKVCDQLKTTFVHPFDILLNN 109805 SFNTK*MMPIKSIVTLDQLEDSEYLFRIVSTVLPHLCLDYKVCDQLKTTFVHPFDILLNN Sbjct 116623 SFNTK*MMPIKSIVTLDQLEDSEYLFRIVSTVLPHLCLDYKVCDQLKTTFVHPFDILLNN 116444 Query 109804 SLGSVTKQDELQAAISKLGINYLIDTTSRELKLFNVTLNAGNIDIINTPINISSETNPII 109625 SLGSVTKQDELQAAISKLGINYLIDTTSRELKLFNVTLNAGNIDIINTPINISSETNPII Sbjct 116443 SLGSVTKQDELQAAISKLGINYLIDTTSRELKLFNVTLNAGNIDIINTPINISSETNPII 116264 Query 109624 NTHSFYDLPPFTQHLLNIRLTDTEYRARFIGGYIKPDGSDSMDVLAEKKYPDLNFDNTYL 109445 NTHSFYDLPPFTQHLLNIRLTDTEYRARFIGGYIKPDGSDSMDVLAEKKYPDLNFDNTYL Sbjct 116263 NTHSFYDLPPFTQHLLNIRLTDTEYRARFIGGYIKPDGSDSMDVLAEKKYPDLNFDNTYL 116084 Query 109444 FNILYKDVINAPIKEFKAKIVNGVLSRQDFDNLIGVRQYITAQDRPRFDNAYNIADAARH 109265 FNILYKDVINAPIKEFKAKIVNGVLSRQDFDNLIGVRQYITAQDRPRFDNAYNIADAARH Sbjct 116083 FNILYKDVINAPIKEFKAKIVNGVLSRQDFDNLIGVRQYITAQDRPRFDNAYNIADAARH 115904 Query 109264 YGVNLNTLPLPNVDLTTMPTYKHLIMFEQYFIYTYDRVDIYYNGNKMLLDDEIMNFCISM 109085 YGVNLNTLPLPNVDLTTMPTYKHLIMFEQYFIYTYDRVDIYYNGNKMLLDDEIMNFCISM Sbjct 115903 YGVNLNTLPLPNVDLTTMPTYKHLIMFEQYFIYTYDRVDIYYNGNKMLLDDEIMNFCISM 115724 Query 109084 RYQSLIPRLVEFFPDIPVNNNIVLHTRDPQNAAVNVTVALPNVQFVDIGRNHKFFINFFN 108905 RYQSLIPRLVEFFPDIPVNNNIVLHTRDPQNAAVNVTVALPNVQFVDIGRNHKFFINFFN Sbjct 115723 RYQSLIPRLVEFFPDIPVNNNIVLHTRDPQNAAVNVTVALPNVQFVDIGRNHKFFINFFN 115544 Query 108904 LLAKEQRSTAIKVTKSMFWDGMDYEEYKSKNLQDMMFINSTCYVFGLYNHNNTTYCSILS 108725 LLAKEQRSTAIKVTKSMFWDGMDYEEYKSKNLQDMMFINSTCYVFGLYNHNNTTYCSILS Sbjct 115543 LLAKEQRSTAIKVTKSMFWDGMDYEEYKSKNLQDMMFINSTCYVFGLYNHNNTTYCSILS 115364 Query 108724 DIISAEKTPIRVCLLPRVVGGKTVTNLISETLKSISSMTIREFPRKDKSIMHIGLSETGF 108545 DIISAEKTPIRVCLLPRVVGGKTVTNLISETLKSISSMTIREFPRKDKSIMHIGLSETGF Sbjct 115363 DIISAEKTPIRVCLLPRVVGGKTVTNLISETLKSISSMTIREFPRKDKSIMHIGLSETGF 115184 Query 108544 MRFFQLLRLMADKPHETAIKEVVMAYVGIKLGDKGSPYYIRKESYQDFIYLLFASMGFKV 108365 MRFFQLLRLMADKPHETAIKEVVMAYVGIKLGDKGSPYYIRKESYQDFIYLLFASMGFKV Sbjct 115183 MRFFQLLRLMADKPHETAIKEVVMAYVGIKLGDKGSPYYIRKESYQDFIYLLFASMGFKV 115004 Query 108364 TTRRsimgsnnisiisIRPKVTKQYIVTTLMKTSCSKNEAEKLITSAFDLLNFMVSVSDF 108185 TTRRSIMGSNNISIISIRP+VTKQYIVTTLMKTSCSKNEAEKLITSAFDLLNFMVSVSDF Sbjct 115003 TTRRSIMGSNNISIISIRPRVTKQYIVTTLMKTSCSKNEAEKLITSAFDLLNFMVSVSDF 114824 Query 108184 RDYQSYRQYRNYCPRYFYAGSPEGEETIICDSEPISILDRIDTRGIFSAYTINEMMDTDI 108005 RDYQSYRQYRNYCPRYFYAGSPEGEETIICDSEPISILDRIDTRGIFSAYTINEMMDTDI Sbjct 114823 RDYQSYRQYRNYCPRYFYAGSPEGEETIICDSEPISILDRIDTRGIFSAYTINEMMDTDI 114644 Query 108004 FSPENKAFKNNLSRFIESGNITGEDIFCAMPYNILDRIITNAGTCTVSIGDMLDNITTQS 107825 FSPENKAFKNNLSRFIESGNITGEDIFCAMPYNILDRIITNAGTCTVSIGDMLDNITTQS Sbjct 114643 FSPENKAFKNNLSRFIESGNITGEDIFCAMPYNILDRIITNAGTCTVSIGDMLDNITTQS 114464 Query 107824 DCNMTNEITDMINASLKNTISKDNNMLVSQALDSVANRSKQTIGDLRQSSCKMALLFKNL 107645 DCNMTNEITDMINASLKNTISKDNNMLVSQALDSVANRSKQTIGDLRQSSCKMALLFKNL Sbjct 114463 DCNMTNEITDMINASLKNTISKDNNMLVSQALDSVANRSKQTIGDLRQSSCKMALLFKNL 114284 Query 107644 ATSIYTIERIFNAKVGDDVKASMLEKYKVFTDISMSLYKDLIAMENLKAMLYIIRRSGCR 107465 ATSIYTIERIFNAKVGDDVKASMLEKYKVFTDISMSLYKDLIAMENLKAMLYIIRRSGCR Sbjct 114283 ATSIYTIERIFNAKVGDDVKASMLEKYKVFTDISMSLYKDLIAMENLKAMLYIIRRSGCR 114104 Query 107464 IDDAQITTDDLVKSYSLIRPKILSMINYYNEMSRGYFEHMKKNLNMTDGDSVSFDDE*MS 107285 IDDAQITTDDLVKSYSLIRPKILSMINYYNEMSRGYFEHMKKNLNMTDGDSVSFDDE*MS Sbjct 114103 IDDAQITTDDLVKSYSLIRPKILSMINYYNEMSRGYFEHMKKNLNMTDGDSVSFDDE*MS 113924 Query 107284 CYTAILKSVGGLALFQVANGAIDLCRHFFMYFCEQKLRPNSFWFVVVRAIASMIMYLVLG 107105 CYTAILKSVGGLALFQVANGAIDLCRHFFMYFCEQKLRPNSFWFVVVRAIASMIMYLVLG Sbjct 113923 CYTAILKSVGGLALFQVANGAIDLCRHFFMYFCEQKLRPNSFWFVVVRAIASMIMYLVLG 113744 Query 107104 IALLYISEQ 107078 IALLYISEQ Sbjct 113743 IALLYISEQ 113717
Could you provide a link to the Prof Burkhardt study?
Invest in $SIGA